Showing 41 - 60 results of 18,428 for search '(( significantly ((a decrease) OR (mean decrease)) ) OR ( significant progress decrease ))', query time: 0.55s Refine Results
  1. 41

    MiR-129-5p levels were decreased in mouse depression models. by Qiaozhen Qin (13159201)

    Published 2025
    “…</b> The KEGG pathway analysis identifies the number of target genes within each pathway. Those with a p-value < 0.05 are considered significant. <b>L.…”
  2. 42
  3. 43
  4. 44
  5. 45

    Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

    Published 2025
    “…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”
  6. 46
  7. 47

    Effects of Kylo-0603 on body weight, organ weight, and body fat content. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
  8. 48

    Table 2_Expression and prognostic significance of the m6A RNA methylation regulator HNRNPC in HNSCC.docx by Yulin Zhang (510822)

    Published 2025
    “…Knockdown of HNRNPC in the HNSCC cell lines HSC-3 and CAL-27 resulted in a significant decrease in proliferation, invasion, and malignant transformation abilities. …”
  9. 49

    Table 1_Expression and prognostic significance of the m6A RNA methylation regulator HNRNPC in HNSCC.docx by Yulin Zhang (510822)

    Published 2025
    “…Knockdown of HNRNPC in the HNSCC cell lines HSC-3 and CAL-27 resulted in a significant decrease in proliferation, invasion, and malignant transformation abilities. …”
  10. 50
  11. 51

    Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3). by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
  12. 52

    Plasma cholesterol and LDL-C levels. by Xueqin lu (22250795)

    Published 2025
    Subjects: “…attenuates fibrosis progression…”
  13. 53
  14. 54
  15. 55
  16. 56
  17. 57
  18. 58
  19. 59
  20. 60